RxSight, Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-08-03: Reporting owner Wolfen Richard M.; Form 4; Security Warrant (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2021-08-03: Reporting owner Robertson Bruce C; Form 4; Security Warrant (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2021-08-03: Reporting owner Tammenoms Bakker Juliet; Form 4; Security Warrant (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2021-07-29: Reporting owner Robertson Bruce C; Form 3; Security Warrant (right to buy); Transaction Holding.
RXST insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-08-03 | Wolfen Richard M. Director | 4 | Warrant (right to buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,452 0 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-08-03 | Robertson Bruce C Director | 4 | Warrant (right to buy) Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −60,503 0 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-08-03 | Tammenoms Bakker Juliet Director | 4 | Warrant (right to buy) Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,302 0 owned after | $12.40 exercise price | $16.35 | 2021-08-05 |
| 2021-07-29 holding as of filing | Robertson Bruce C Director | 3 | Warrant (right to buy) Derivative · Indirect · See footnote | Holding | $12.40 exercise price | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Wolfen Richard M. Director | 3 | Warrant (right to buy) Derivative · Direct · (m) | Holding | $12.40 exercise price | 2021-07-29 | ||
| 2021-07-29 holding as of filing | Tammenoms Bakker Juliet Director | 3 | Warrant (right to buy) Derivative · Indirect · See footnote | Holding | $12.40 exercise price | 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |